Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06XHC
|
|||
| Former ID |
DAP001044
|
|||
| Drug Name |
Amcinonide
|
|||
| Synonyms |
Amcinonida; Amcinonido; Amcinonidum; Cyclocort; Cyclort; Triamcinolonacetatcyclopentanonid; Visderm; CL 34699; Amcinonido [INN-Spanish]; Amcinonidum [INN-Latin]; CL 34,699; CL-34699; Cyclocort (TN); Amcinonide (JAN/USP/INN); Amcinonide [USAN:INN:BAN:JAN]; Triamcinolone 16,17-cyclopentylidenedioxy-21-acetate; 1,4-Pregnadiene-2,20-dione-16,17-cyclopentylidenedioxy-9-fluoro-11,21-dihydroxy-21-acetate; 16alpha,17alpha-(cyclopentane-1,1-diyldioxy)-9-fluoro-11beta-hydroxy-3,20-dioxopregna-1,4-dien-21-yl acetate; 19alpha-Fluor-11beta,21-dihydroxy-16alpha,17alpha-(tetramethylen)methylendioxy-1,4-pregnadien-3,20-dion 21-acetat; 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclopentanone, 21-acetate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Approved | [1], [2] | |
| Therapeutic Class |
Antiinflammatory Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H35FO7
|
|||
| Canonical SMILES |
CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC6(O2)CCCC6
|
|||
| InChI |
1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1
|
|||
| InChIKey |
ILKJAFIWWBXGDU-MOGDOJJUSA-N
|
|||
| CAS Number |
CAS 51022-69-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
855515, 7848450, 7978681, 10299444, 15084976, 24890657, 36887100, 46506705, 50926096, 56352910, 56422434, 56423154, 57404572, 57653835, 71825482, 92712334, 93576974, 99368349, 103770715, 104631033, 124801285, 126625654, 126656779, 134338306, 135001553, 135653543, 136014083, 137005249, 138911215, 139999915, 144204964, 152100586, 160963636, 162198485, 175266120, 175612165, 178103639, 179116554, 226396660, 241090273, 250133950, 252401183
|
|||
| ChEBI ID |
CHEBI:31199
|
|||
| ADReCS Drug ID | BADD_D00101 | |||
| SuperDrug ATC ID |
D07AC11
|
|||
| SuperDrug CAS ID |
cas=051022696
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Steroid hormone receptor ERR (ESRR) | Target Info | Modulator | [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7060). | |||
| REF 2 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 076065. | |||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.